Clinical Trials Directory

Trials / Sponsors / Santaris Pharma A/S

Santaris Pharma A/S

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
UnknownMiravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus R
Hepatitis C, Chronic
Phase 22013-06-01
UnknownMiravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatiti
Hepatitis C
Phase 22012-11-01
CompletedDrug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects
Hepatitis C, Chronic Hepatitis C
Phase 12012-06-01
TerminatedMultiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH
Hypercholesterolemia
Phase 12011-05-01
CompletedMultiple Ascending Dose Study of SPC4955 in Healthy Subjects
Hypercholesterolemia
Phase 12011-05-01
CompletedMultiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects
Hepatitis C
Phase 22010-09-01
CompletedSPC3649 Multiple Dose Study in Healthy Volunteers
Hepatitis C
Phase 12009-09-01
CompletedSafety Study of SPC3649 in Healthy Men
Hepatitis C
Phase 12008-05-01
CompletedSPC2996 in Chronic Lymphocytic Leukaemia
Chronic Lymphocytic Leukemia
Phase 1 / Phase 22005-06-01